World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 5 May 2019
Main ID:  ChiCTR1900022715
Date of registration: 2019-04-23
Prospective Registration: Yes
Primary sponsor: Tianjin Huanhu Hospital
Public title: Accurate treatment under the multidisciplinary cooperative diagnosis and treatment model of Parkinson's disease
Scientific title: Accurate treatment under the multidisciplinary cooperative diagnosis and treatment model of Parkinson's disease
Date of first enrolment: 2019-05-01
Target sample size: Anteversion group:40;Balance dysfunction group:40;Gait abnormality group:40;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=35352
Study type:  Observational study
Study design:  Factorial  
Phase:  N/A
Countries of recruitment
China
Contacts
Name: Siquan Liang   
Address:  6 Jizhao Road, Jinnan District, Tianjin
Telephone: +86 13114862005
Email: liangsiquan@163.com
Affiliation:  Tianjin Huanhu Hospital
Name: Haitao Li   
Address:  6 Jizhao Road, Jinnan District, Tianjin
Telephone: +86 18622115251
Email: sdzclht@163.com
Affiliation:  Tianjin Huanhu Hospital
Key inclusion & exclusion criteria
Inclusion criteria: 1 Conforms to the PD PD of the UK PD or the primary diagnostic criteria of PD in China.
2 Course > 5 years of diagnosis of primary PD patients.
3 Levodopa impact test improved > 30%.
4 Aged = 75 years.
5 The efficacy of the drug is significantly reduced or there is motor fluctuation or dyskinesia, which affects the quality of life of patients.
6 Severity of illness: "off" period Hoehn-Yahr (H-Y) 2. 5 ~ 4 period.
7 Reasonable postoperative expectation. 8 no surgical contraindications

Exclusion criteria: 1. Obvious cognitive dysfunctions;
2. Severe (refractory) depression, anxiety, schizophrenia and other mental illnesses;
3. Medical coexisting diseases affect surgery or survival.


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Parkinson's Disease
Intervention(s)
Anteversion group:DBS;Balance dysfunction group:DBS;Gait abnormality group:DBS;
Primary Outcome(s)
angle of anteversion;gait;stability;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Tianjin Huanhu Hospital
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 03/04/2019
Contact:
Ren Feng
+86 022 59065824
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history